MACROGENICS INC·4

Feb 10, 6:15 PM ET

Peters Jeffrey Stuart 4

Research Summary

AI-generated summary

Updated

MacroGenics (MGNX) SVP Jeffrey Peters Receives 15,000 Shares (Vested RSUs)

What Happened
Jeffrey Stuart Peters, Senior Vice President, General Counsel and Secretary of MacroGenics (MGNX), had restricted stock units (RSUs) convert into 15,000 shares on Feb 7–8, 2026 (6,001 and 8,999 shares). To cover tax withholding, 2,317 and 3,474 shares were surrendered at $1.81 per share (proceeds reported as $4,194 and $6,288). The RSU conversions are reported as derivative conversions (Form 4 code M) with the withholding reported as a disposition for tax liability (code F).

Key Details

  • Transaction dates: Feb 7, 2026 (6,001 shares) and Feb 8, 2026 (8,999 shares).
  • Withheld for taxes: 2,317 shares (Feb 7) and 3,474 shares (Feb 8) at $1.81/share = $4,194 and $6,288; total withheld = 5,791 shares (~$10,482).
  • Net shares delivered to insider: 15,000 vested − 5,791 withheld = 9,209 shares.
  • Footnotes: RSUs convert 1-for-1 (F1). The vested RSUs come from grants of 18,000 RSUs on Feb 7, 2025 (vested in thirds) and 27,000 RSUs on Feb 8, 2024 (vested in thirds) (F2, F3).
  • Filing: Report filed Feb 10, 2026 (covers transactions dated Feb 7–8); filing appears within the normal Form 4 reporting window.
  • Shares owned after the transaction: not specified in this filing.

Context
These entries reflect routine RSU vesting and tax-withholding (a non-market sale to satisfy tax obligations), not an open-market sale or purchase. The derivative code (M) here represents conversion of RSUs into common stock; the F-code disposals are shares withheld for taxes (a cashless withholding). Such withholding is standard and does not necessarily indicate the insider’s market view.